옵션 체인은 다양한 행사가격과 만기일에 대한 Quhuo의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Quhuo에 대한 시장 심리를 평가합니다..

Quhuo (NASDAQ:QH) 주식, 옵션 체인

Quhuo

Quhuo Ltd is a gig economy platform in China. The company provides tech-enabled, end-to-end operational solutions to consumer service businesses in industries with e-commerce exposure, including food delivery, ride-hailing, housekeeping, bike-sharing, and other services. The company generates revenue predominantly from service fees paid by its industry customers, and to a lesser extent, from rental fees under its car leasing agreements with drivers engaged in the ride-hailing solutions. It derives all of its revenue from the PRC. The company's revenues are categorized into On-demand delivery solutions; Mobility service solutions; Housekeeping solutions and other services. The On-demand delivery solutions generate key revenue for the firm.

Exclusives

Trading Ideas

AAPL

AMZN

APLD

CNEY

GLMD

GOVX

IMRX

INTC

LUMN

LUNR

NDRA

NVDA

PLTR

SMCI

SMMT

TNON

TSLA

WHLR

매일 거래일마다 벤징가 프로(Benzinga Pro)에서 수백 개의 헤드라인과 보도자료가 올라온다. 이는 트레이더들이 전체 시장 및 개별 종목에 대한 최신 뉴스를 확인할 수 있는 소스이다. 2024년 9월에 Benzinga Pro에서 가장 많이 검색된 주식들을 살펴보겠다. 현재 가격과 연초 대비 성과는 9월 30일 기준이며 배당금은 포함되지 않았다.

독점: 9월 벤징가 프로에서 가장 많이 검색된 상위 20개 티커 - 테슬라, 엔비디아, 애플은 어디에?

Quhuo Limited - American Depository Shares

Quhuo Ltd

Innovator Hedged Nasdaq-100 ETF

WisdomTree U.S. High Yield Corporate Bond Fund

QHY Group

QHSLab Inc

QHY GROUP by QHY Group

News

ADTX

Aditxt'ss Adimune Subsidiary To Ship Drug Substances For Final Drug Product Formulation Of ADI-100 Ahead Of Planned Trials For Type 1 Diabetes And Psoriasis In Germany And Stiff Person Syndrome At Mayo Clinic

<p>B of A Securities  analyst Peter Galbo   maintains Campbell`s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Underperform and lowers the price target from $45 to $41.</p>


Price Target

Analyst Ratings

B of A Securities Maintains Underperform on Campbell's, Lowers Price Target to $41

<p>Small Cap Consumer Research  analyst Eric Beder   reiterates Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) with a Buy and maintains $5.5 price target.</p>


Reiteration

Small Cap Consumer Research Reiterates Buy on Vera Bradley, Maintains $5.5 Price Target

WIIM

VRME

VerifyMe shares are trading lower after the company reported worse-than-expected Q4 earnings and sales.

Contracts

MRAM

Everspin Awarded $10.5M Contract For MRAM IP And Foundry Services For Purdue University's ME Commons In-Memory Compute Project

<p>Baird  analyst Shrenik Kothari   maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Outperform and raises the price target from $240 to $250.</p>


Baird Maintains Outperform on Zscaler, Raises Price Target to $250

Earnings

Earnings Beats

Earnings Misses

VYNE

VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate

<p>Baird  analyst Joe Vruwink   maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Outperform and raises the price target from $283 to $285.</p>


VEEV

Baird Maintains Outperform on Veeva Systems, Raises Price Target to $285

ALLR

Allarity Therapeutics Announces ITs Phase 2 Trial Of Stenoparib In Combination With Temozolomide For Recurrent Small Cell Lung Cancer, Being Fully Funded By US Veterans Administration

<p>Baird  analyst William Power   maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Outperform and lowers the price target from $390 to $300.</p>


Baird Maintains Outperform on MongoDB, Lowers Price Target to $300

Curtiss-Wright Receives $18M Follow-On Order From US Marine Corps

<p>No gainer in today's Pre-market session. </p>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">217.58</td>
<td align="right">-3.99</td>
<td align="right">-1.81</td>
<td>19.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">49.70</td>
<td align="right">-0.51</td>
<td align="right">-1.02</td>
<td>255.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">209.31</td>
<td align="right">-2.10</td>
<td align="right">-1.00</td>
<td>364</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">76.95</td>
<td align="right">-0.54</td>
<td align="right">-0.70</td>
<td>5.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">148.93</td>
<td align="right">-0.75</td>
<td align="right">-0.51</td>
<td>4.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.20</td>
<td align="right">-0.22</td>
<td align="right">-0.51</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">82.06</td>
<td align="right">-0.38</td>
<td align="right">-0.47</td>
<td>1.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">85.34</td>
<td align="right">-0.36</td>
<td align="right">-0.43</td>
<td>13.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">87.84</td>
<td align="right">-0.20</td>
<td align="right">-0.23</td>
<td>326</td>
</tr>
</tbody>
</table>
<p><a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. </p>
<p><em>To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.</em> </p>


Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For March 6, 2025

Tesla shares are trading lower after Baird lowered its price target on the stock from $440 to $370.

<p>Baird  analyst Craig Kennison   maintains Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) with a Outperform and lowers the price target from $110 to $100.</p>


Baird Maintains Outperform on Thor Industries, Lowers Price Target to $100

BECN

Beacon Acquires DM Figley, Terms Not Disclosed

CNTM

ConnectM Secured Over 5,500 Orders For MELI Mobility Edge And AURAI Platform Subscriptions From Existing OEM Customers In First Two Months Of 2025

<p>Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(1.27) by 37.8 percent. This is a 1.25 percent increase over losses of $(0.80) per share from the same period last year.  The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent.  This is a 4.25K percent increase over sales of $682.00 thousand the same period last year.</p>


PHAT

Phathom Pharmaceuticals Q4 Adj $(0.79) Beats $(1.27) Estimate, Sales $29.66M Beat $24.91M Estimate

<p>Baird  analyst Jonathan Komp   maintains Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) with a Neutral and lowers the price target from $24 to $20.</p>


Baird Maintains Neutral on Foot Locker, Lowers Price Target to $20

<p>Baird  analyst Ben Kallo   maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and lowers the price target from $440 to $370.</p>


Baird Maintains Outperform on Tesla, Lowers Price Target to $370

LFMD

LifeMD Announces Integration With LillyDirect Pharmacy Provider Gifthealth To Offer Access To Branded Dual GLP-1/GIP Zepbound

Entertainment

Press Releases

General

Quhuo's Homestay Sector Reports Impressive Performance During Labor Day Holiday with Sales Surge Year-on-Year

Quhuo to Report Unaudited Financial Results for the First Half of 2024 on August 28, 2024

Quhuo Announces Unaudited Financial Results for the First Half of 2024: Precise Strategy Spurs Strong Growth in Mobility Service and Homestay

Quhuo Reports Unaudited Financial Results for the First Half of 2024

Quhuo International Establishes Strategic Partnership in Azerbaijan: Promoting Chinese Electric Vehicle Exports and Enhancing Local Life Services

From Delivery Rider to Model Worker: Quhuo "Empowering Workers" Sets Industry Benchmark

Quhuo's Homestay Sector Announces Strategic Upgrade: Launches New Booking Platform and Six Functional Room Types

Quhuo Regains Compliance with Nasdaq Continued Listing Requirements

Quhuo's Homestay Sector Hits New Highs During National Day with Multiple Initiatives to Enhance Guest Experience

Quhuo International Partners with Panasonic Navinfo to Strengthen NEV Export Assurance

Comments

Quhuo

Quhuo (QH) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌